Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recordati and Merck Serono to comarket pitavastatin calcium in France

Dec. 31, 2010

FDA approves Fortesta for hypogonadism

Dec. 31, 2010

Actavis launches risedronate in four European countries

Dec. 31, 2010

Boehringer Ingelheim Pharma describes new 11-beta-HSD1 inhibitors

Dec. 31, 2010

Repros Therapeutics submits analyzed data on Androxal to FDA

Dec. 31, 2010

New partial agonists of PPAR-gamma disclosed

Dec. 30, 2010

Florida Hospital, Sanford-Burnham and Takeda partner to target obesity

Dec. 30, 2010

New activators of glycoprotein hormone FSH receptor discovered

Dec. 30, 2010

BioSante raises funds to support phase III LibiGel program

Dec. 29, 2010

FDA requires additional time to review Afrezza NDA

Dec. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...